Gene: AASDH
Official Full Name: aminoadipate-semialdehyde dehydrogenaseprovided by HGNC
Gene Summary: This gene encodes a member of the non-ribosome peptide syntesase (NRPS) enzyme family. The encoded protein contains an AMP-binding domain, PP-binding (phosphopantetheine, or pantetheine 4'phosphate-binding) domain and the Pyrrolo-quinoline quinon (PQQ) binding domain. The protein is expressed in several adult tissues. [provided by RefSeq, Apr 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO26503 | AASDH Knockout cell line (HeLa) | Human | AASDH | 1:3~1:6 | Negative | Online Inquiry |
KO26504 | AASDH Knockout cell line (HCT 116) | Human | AASDH | 1:2~1:4 | Negative | Online Inquiry |
KO26505 | AASDH Knockout cell line (HEK293) | Human | AASDH | 1:3~1:6 | Negative | Online Inquiry |
KO26506 | AASDH Knockout cell line (A549) | Human | AASDH | 1:3~1:4 | Negative | Online Inquiry |
AASDH Gene Knockout Cell Lines are genetically engineered cell lines specifically designed to silence the AASDH (aspartate alpha-decarboxylase) gene through the technique of CRISPR-Cas9 or similar gene-editing approaches. This product allows researchers to explore the biological roles and functions of AASDH by observing the phenotypic changes that occur when this gene is disrupted. The AASDH gene is critical in various metabolic pathways, particularly in the metabolism of amino acids and neurotransmitters, making these knockout lines invaluable for studying altered metabolism, neurobiology, and related disease models.
The primary mechanism of action relies on the precise editing of the genomic DNA, leading to a complete or nearly complete loss of function of the AASDH protein. This functional knockout provides a powerful means for scientists to investigate the underlying molecular mechanisms associated with AASDH deficiency, including its implications in pathologies such as neurological disorders, metabolic syndromes, and potential therapeutic targets.
From a scientific perspective, these cell lines serve as essential tools in both research and clinical settings. They facilitate drug discovery efforts, allowing for the screening of compounds that could restore normal function or mitigate pathological conditions linked to AASDH. Beyond their applications in basic research, they can aid in the development of gene therapies aimed at correcting metabolic dysfunctions.
The AASDH Gene Knockout Cell Lines stand out due to their robust phenotype confirmation and comprehensive data accompanying each line, including validated knockout efficiency and stability across multiple passages. Compared to alternative gene-editing products, this offering minimizes variability and enhances reproducibility, key elements needed for rigorous scientific inquiry.
For researchers and clinicians interested in understanding the intricate roles of the AASDH gene, these cell lines provide a valuable resource to elucidate mechanisms of disease and therapeutic development. With years of expertise in developing high-quality biological products, our company remains committed to advancing research through innovative solutions like the AASDH Gene Knockout Cell Lines, ensuring that scientists have access to the tools necessary for groundbreaking discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.